Long pages

Jump to navigation Jump to search

Showing below up to 50 results in range #43,621 to #43,670.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. (hist) RETSAT [4,625 bytes]
  2. (hist) Disseminated intravascular coagulation history and symptoms [4,625 bytes]
  3. (hist) Ataxia telangiectasia (patient information) [4,625 bytes]
  4. (hist) XPNPEP2 [4,625 bytes]
  5. (hist) List of omics topics in biology [4,625 bytes]
  6. (hist) Sensory phenomena [4,625 bytes]
  7. (hist) MEDEVAC [4,625 bytes]
  8. (hist) Ionian Technologies [4,625 bytes]
  9. (hist) Sarcoptes scabiei [4,625 bytes]
  10. (hist) Iron-sulfur protein [4,625 bytes]
  11. (hist) Decidua [4,625 bytes]
  12. (hist) Paroxysmal supraventricular tachycardia classification [4,624 bytes]
  13. (hist) WBR0729 [4,624 bytes]
  14. (hist) Methemoglobinemia overview [4,624 bytes]
  15. (hist) Oncocytoma causes [4,624 bytes]
  16. (hist) Cobalt-60 [4,624 bytes]
  17. (hist) Telmisartan is as effective and safe as ramipril in patients at high risk for vascular events: Results from the ONTARGET trial [4,624 bytes]
  18. (hist) BBCH-scale (sunflower) [4,624 bytes]
  19. (hist) Charity Guide [4,624 bytes]
  20. (hist) Piriformis muscle [4,624 bytes]
  21. (hist) Posterior branches of cervical nerves [4,624 bytes]
  22. (hist) Cronkhite–Canada disease [4,624 bytes]
  23. (hist) CRIP1 [4,623 bytes]
  24. (hist) Chronic myelogenous leukemia staging [4,623 bytes]
  25. (hist) Oxford Health Alliance [4,623 bytes]
  26. (hist) N400 [4,623 bytes]
  27. (hist) Konjac [4,623 bytes]
  28. (hist) Brodmann area 19 [4,623 bytes]
  29. (hist) Neck [4,623 bytes]
  30. (hist) MicroRNA 499a [4,622 bytes]
  31. (hist) Leptospirosis risk factors [4,622 bytes]
  32. (hist) Rifabutin clinical pharmacology [4,622 bytes]
  33. (hist) WBR0825 [4,622 bytes]
  34. (hist) WBR0407 [4,622 bytes]
  35. (hist) Hepatic cysts classification [4,622 bytes]
  36. (hist) Alcoholic hepatitis secondary prevention [4,622 bytes]
  37. (hist) The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Warfarin Suggest Revisions to the CLASS I Guidelines [4,622 bytes]
  38. (hist) Cell adhesion [4,622 bytes]
  39. (hist) Occipital bone [4,622 bytes]
  40. (hist) Gandhi Medical College [4,622 bytes]
  41. (hist) Equating [4,622 bytes]
  42. (hist) G. D. Searle & Company [4,622 bytes]
  43. (hist) Beta-peptide [4,622 bytes]
  44. (hist) CAACTC regulatory element gene transcriptions [4,621 bytes]
  45. (hist) Postpartum thyroiditis physical examination [4,621 bytes]
  46. (hist) Cefoxitin indications and usage [4,621 bytes]
  47. (hist) Valvular heart disease cardiac catheterization [4,621 bytes]
  48. (hist) Aortic regurgitation surgery recovery [4,621 bytes]
  49. (hist) Progeria (patient information) [4,621 bytes]
  50. (hist) Kringle domain [4,621 bytes]

View ( | ) (20 | 50 | 100 | 250 | 500)